Pfizer’s Vitiligo Pill Shows Promise as Doctors Explain Why the Condition Is More Than Skin Deep

Pfizer says Phase 3 trials show Litfulo helped restore skin pigmentation in nonsegmental vitiligo, marking a promising advance in treatment.

Have A Referral?